Veterinary Therapeutics Market to reach USD 82.40 Billion By 2032, Growing at a CAGR of 7.35%
The veterinary therapeutics market is experiencing significant growth, driven by rising awareness of animal health, advancements in veterinary medicine, and the growing prevalence of animal diseases. The increasing trend of pet humanization has been a major catalyst, with pet owners prioritizing the health and well-being of their animals. According to the American Pet Products Association, nearly 67% of U.S. households own a pet, reflecting a growing investment in veterinary care. Pet owners are increasingly seeking advanced treatments, such as therapies for arthritis, diabetes, and cancer, demonstrating the rising demand for effective veterinary solutions.